Radiosensitivity Enhancement by Combined Treatment of Nimotuzumab and Celecoxib on Nasopharyngeal Carcinoma Cells Retraction

Puntos clave

• To assess the effects of combined treatment with nimotuzumab and celecoxib on nasopharyngeal carcinoma cells.
• Conducted experiments on nasopharyngeal carcinoma cells
• Evaluated radiosensitivity using different treatment conditions
• Employed western blot analyses for protein expression assessment
• Identified unusual similarities in image panels of different treatment conditions
• Detected unexpected similarities in western blot bands across experimental conditions
• Raised concerns about the validity of findings due to potential misrepresentations